Basel Medical Group Ltd BMGL
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS—
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Revenue | $8.9M | — |
| Net income | -$8.4M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 |
|---|---|---|
| Total assets | $14.7M | — |
| Total equity | $4.3M | $5.6M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-009978.
Others in SIC 8011
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| HIMS | Hims & Hers Health, Inc. | $6.42B | 54.3x | 59.0% |
| TDOC | Teladoc Health, Inc. | $1.14B | — | -1.5% |
| STLN | Starling Oncology, Inc. | $604.4M | — | 27.8% |
| SBC | SBC Medical Group Holdings Inc | $423.7M | 8.2x | -15.5% |
| AIRS | Airsculpt Technologies, Inc. | $201.5M | — | -15.8% |
| LFMD | LifeMD, Inc. | $148.5M | 12.3x | 25.3% |
| CCM | Concord Medical Services Holdings Ltd | — | — | 26.6% |